Fig. 4

Systemic adverse reactions reported within 7 days after injection of NVSI-06-07 or BBIBP-CorV. Adverse reactions are graded according to the scale issued by the China National Medical Products Administration (NMPA). Grade 1 is mild, grade 2 is moderate, and grade 3 is severe